USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Mapping the Market for Investment, Best Practices, and Growth Potential
26-May-2014
Asia Pacific
Market Research
P7F9-01-00-00-00
LS00141-AP-MR_16982
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and provides an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies. The infectious disease IVD market in Indonesia can be divided into segments such as microbiology testing, immunochemistry testing, and molecular diagnostics testing. The study covers the period 2012 to 2017.
Key Findings
Key Findings (continued)
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Game-changing Strategies
Three Big Predictions
Market Definitions
Research Scope and Objectives
Indonesia Overview
Market Background
Market Background (continued)
Market Segmentation
Reimbursement Overview
PEST Analysis
New Market Opportunities
New Market Opportunities (continued)
Market Share
Market Share Analysis
Competitive Environment
Multinational Versus Local Participants
Merger, Acquisition, and Partnership Assessment
Market Engineering Measurements
Forecast Assumptions
Forecast Assumptions (continued)
Revenue Forecast
Revenue Forecast Discussion
Per cent Revenue Forecast by Segment
Segment Life Cycle Analysis
Key Segment Trends
Immunochemistry Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Competitive Environment
Microbiology Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Competitive Environment
Molecular Diagnostics Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Competitive Environment
Conclusions
Strategic Recommendations
Legal Disclaimer
Market Engineering Methodology
Learn More—Next Steps
Table of Acronyms Used
Table of Acronyms Used (continued)
Roche
Abbott
Bio-Merieux
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Author | Sanjeev Kumar |
| WIP Number | P7F9-01-00-00-00 |
| Is Prebook | No |
Indonesian Infectious Disease IVD Market
$4,950.00
Special Price $3,712.50 save 25 %